Control Resonant: Remedy's Self-Publishing Bold Leap
A sequel priced like AAA but a bet that could flip the studio's financial fortunes
REMEDY.HE · Earnings Call · 2026-08-11
A Quarter of Transition
Remedy's Q2 2026 headline numbers are jarring at first glance: revenue fell 40% year-over-year to EUR 10.2 million, with EBITDA at minus EUR 2.4 million and EBIT at minus EUR 3.9 million. But the CFO, Santtu Kallionpaa, quickly contextualized the decline as a timing artifact—the comparison quarter included the launch of FBC: Firebreak and its initial subscription accruals. Meanwhile, the studio was investing heavily in marketing for its upcoming self-published sequel, CONTROL Resonant. As JC Gaudechon noted, "marketing for CONTROL Resonant ramped up during the quarter, reducing profitability as anticipated." “This is Remedy developing and self-publishing the sequel to CONTROL, our own IP, our own voice and our most ambitious release to date.” — Jean-Charles Gaudechon, CEO · 2026-08-11
The contrast with the prior year's Firebreak launch is instructive. Firebreak, a cooperative multiplayer spin-off, was the first self-published title but it underperformed, and its disappointing reception weighed on the studio. In the Q1 2026 call, the incoming CEO had already pivoted priorities: “Today, it's to execute on CONTROL Resonant. We can have all the strategies in the world, if we don't make an incredible game, what's the point?” — Jean-Charles Gaudechon, Chief Executive Officer · 2026-05-05 That execution is now visible in the numbers.
CONTROL Resonant: The Launch Bet
The marketing ramp is delivering concrete commercial indicators. As of the call, CONTROL Resonant had amassed over 1.5 million wishlists across platforms—a figure the CEO emphasized is net of cancellations. “1.5 million wishlist is an achievement. We're very happy about where we stand, and we're pretty much on track with what we were planning.” — Jean-Charles Gaudechon, CEO · 2026-08-11 Preorders are tracking ahead of prior Remedy titles, with the game ranking among the top three preordered on PlayStation in the U.S., Germany, and Brazil. “Preorders are positive also. As I mentioned in the slides, we're very happy about being in top preorders in the kind of window that we released that or did that announcement.” — Jean-Charles Gaudechon, CEO · 2026-08-11
What sets this launch apart is Remedy's day 1 availability on all major platforms for the first time—a logistical feat that underpins the self-publishing strategy. The price point, $59.99 for the standard edition, is deliberately positioned as "AAA quality at an attractive price against comparable titles in autumn." The CEO acknowledged the crowded September window but argued that quality and uniqueness are the real differentiators. In the early 2026 call, the interim CEO had been coy about marketing plans: “I think we will let our actions speak on that behalf rather than spoil the surprise. You will be hearing more about CONTROL Resonant soon, let's say it that way.” — Markus Maki, Interim CEO · 2026-02-16 That silence has now broken into a full-throated campaign.
China and Localization: New Frontiers
A key strategic thread is the deliberate push into China. The CEO, who has spent considerable time in the region, framed it as a data-driven decision: "our data has shown that CONTROL has done really well in China. This is a franchise that resonates well in China." “China is a priority for us along all our core market. And the reason for that, by the way, is our data has shown that CONTROL has done really well in China.” — Jean-Charles Gaudechon, CEO · 2026-08-11 The game includes full Chinese voice-over, and the studio made a notable appearance at ChinaJoy in Shanghai with a promising local reception. This emphasis on Chinese gamers represents a genuine expansion beyond Remedy's traditional Western audience—one that could meaningfully broaden the total addressable market for its narrative-driven titles.
Localization extends beyond China; the CEO acknowledged disappointed fans in MENA but affirmed that high-quality localization is a strategic priority. The self-publishing model allows Remedy to control these decisions directly, rather than deferring to a third-party publisher.
The Financial Mechanics of Self-Publishing
Self-publishing fundamentally changes the financial profile. For the first time, Remedy is receiving preorders as a self-publisher, and the CFO walked through the IFRS treatment: preorders are not recognized as revenue until the game is delivered; only then do platform fees and royalties accrue. This means the Q2 figures do not include any CONTROL Resonant preorder revenue—the cash and revenue impact will hit post-launch in Q4. “The peak of the marketing cost and the investments made, it will happen around the launch window... the second half of the year is greater in marketing cost than the first half of the year.” — Santtu Kallionpaa, CFO · 2026-08-11 That front‑loaded expense profile explains why profitability is expected to remain under pressure in Q3, but it also sets up a potential step-change in revenue once the game launches on September 24.
Operationally, the studio has continued to reduce external development spend—outsourcing costs fell to EUR 2.6 million, down sharply year-over-year—while capitalizing development expenses into CONTROL Resonant. This discipline, combined with the strong preorder and wishlist momentum, gives the full‑year guidance (revenue and EBITDA to increase) a credible foundation.
As Remedy approaches its most consequential launch since Alan Wake 2, the market is effectively pricing in a binary outcome: either CONTROL Resonant becomes the franchise engine that justifies the self-publishing pivot, or it risks repeating the Firebreak disappointment. The early indicators are encouraging, but the true test will come when the game ships and the backlog of preorders converts into recognized revenue. For a studio that has long been known for quality but struggled to monetize its IP, this is a pivotal moment.